天堂网亚洲,天天操天天搞,91视频高清,菠萝蜜视频在线观看入口,美女视频性感美女视频,95丝袜美女视频国产,超高清美女视频图片

Welcome to chemicalbook!
Chinese English Japanese Germany Korea
400-158-6606
Try our best to find the right business for you.
Do not miss inquiry messages Please log in to view all inquiry messages.

Welcome back!

ChemicalBook CAS DataBase List Deucravacitinib
1609392-27-9

Deucravacitinib synthesis

10synthesis methods
Lewis acid-mediated SNAr reaction of pyridazine 15.12 and aniline 15.7 gave 15.13 in 95% yield with excellent regioselectivity (~185:1 15.13:15.14). Although an unconventional compound, 15.13 was isolated as a Zn-dicarboxylate due to its good solubility, ease of crystallization and isolation. The aryl pyridazine 15.13 then formed a C-N bond with amide 15.15 under Pd catalysis to afford the penultimate carboxylate 15.16 in 94% yield. Trideuterated methylamides were generated under standard amide coupling conditions. Deucravacitinib was prepared in 75% yield by crystallization in NMP and i-PrOH.
6228-73-5 Synthesis
CYCLOPROPANECARBOXAMIDE

6228-73-5
238 suppliers
$5.00/1g

BMS-986165 Related Compound 6

1609394-23-1
6 suppliers
inquiry

Deucravacitinib

1609392-27-9
185 suppliers
inquiry

-

Yield:1609392-27-9 46%

Reaction Conditions:

with tris-(dibenzylideneacetone)dipalladium(0);caesium carbonate;4,5-bis(diphenylphosphino)-9,9-dimethylxanthene in 1,4-dioxane at 130; for 2.33333 h;Sealed tube;Inert atmosphere;

Steps:

52.2 Example
Step 2[00220j Intl3 (2.32 g, 6.16 mmol) and cyclopropanecarboxamide (1.048 g, 12.31 mmol) were dissolved in dioxane (62 mL) and Pd2(dba)3 (564 mg, 0.6 16 mmol), Xantphos (534 mg, 0.924 mmol) and cesium carbonate (4.01 g, 12.3 mmol) were added.The vessel was evacuated three times (backfilling with nitrogen) and then sealed and heated to 130 °C for 140 minutes. The reaction was filtered through CELITE (eluting with ethyl acetate) and concentrated (on smaller scale this material could then be purified using preparative HPLC). The crude product was adsorbed onto CELITE using dichloromethane, dried and purified using automated chromatography (100% EtOAc)provide example 52 (1.22 g, 46% yield). ‘H NMR (500MHz, chloroform-d) ? 10.99 (s,1H), 8.63 (s, 1H), 8.18 (s, 1H), 8.10 (d, J=0.5 Hz, 2H), 7.81 (dd, J7.9, 1.7 Hz, 1H), 7.51(dd, J7.9, 1.4 Hz, 1H), 7.33 - 7.20 (m, 7H), 4.01 (d, J0.3 Hz, 3H), 3.82 (s, 3H), 1.73 -1.60 (m, 1H), 1.16 - 1.06 (m, 2H), 0.97 - 0.84 (m, 2H). LC retention time 6.84 [N].MS(Ej m/z: 426 (MHj

References:

BRISTOL-MYERS SQUIBB COMPANY;MOSLIN, Ryan M.;WEINSTEIN, David S.;WROBLESKI, Stephen T.;TOKARSKI, John S.;KUMAR, Amit WO2014/74661, 2014, A1 Location in patent:Paragraph 00220

FullText

1609394-10-6 Synthesis
2-methoxy-3-(1-methyl-1H-1,2,4-triazol-3-yl)aniline

1609394-10-6
160 suppliers
inquiry

Deucravacitinib

1609392-27-9
185 suppliers
inquiry